Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danxia Zhu

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Clinical and Experimental Medicine|December 3, 2015
Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysisDanxia Zhu, Xiao-Li Xu, Cheng Fang, et al.
The American Journal of the Medical Sciences|July 30, 2019
The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian CancerWeiwei Wang, Yin Yin, Xia Shan, et al.
Scientific Reports|December 22, 2016
Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched AnalysisYiting Geng, Yingjie Shao, Danxia Zhu, et al.
The Journal of Pathology|June 20, 2025
Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinomaMengjie Yu, Dou Yang, Danxia Zhu, et al.
International Journal of Clinical and Experimental Medicine|September 18, 2015
Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cell lymphoma: a systematic review and meta-analysisCheng Fang, Danxia Zhu, Huajie Dong, et al.
Peerj|May 31, 2021
MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancerShiyu Zhang, Cheng Liu, Xuan Zou, et al.
Cancer Chemotherapy and Pharmacology|October 14, 2011
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAPWei Zhu, Huaguo Xu, DanXia Zhu, et al.
Molecular Cancer|October 15, 2025
Purine metabolism: a pan-cancer metabolic dysregulation across circulation and tissuesMengjie Yu, Cheng Liu, Minmin Cao, et al.
Clinical Science (London, England : 1979)|May 22, 2019
Hsa_circ_0009361 acts as the sponge of miR-582 to suppress colorectal cancer progression by regulating APC2 expressionYiting Geng, Xiao Zheng, Wenwei Hu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 20, 2018
IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUADChen Wu, Xiaodong Li, Dachuan Zhang, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Clinical and Experimental Medicine|December 3, 2015
Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysisDanxia Zhu, Xiao-Li Xu, Cheng Fang, et al.
The American Journal of the Medical Sciences|July 30, 2019
The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian CancerWeiwei Wang, Yin Yin, Xia Shan, et al.
Scientific Reports|December 22, 2016
Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched AnalysisYiting Geng, Yingjie Shao, Danxia Zhu, et al.
The Journal of Pathology|June 20, 2025
Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinomaMengjie Yu, Dou Yang, Danxia Zhu, et al.
International Journal of Clinical and Experimental Medicine|September 18, 2015
Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cell lymphoma: a systematic review and meta-analysisCheng Fang, Danxia Zhu, Huajie Dong, et al.
Peerj|May 31, 2021
MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancerShiyu Zhang, Cheng Liu, Xuan Zou, et al.
Cancer Chemotherapy and Pharmacology|October 14, 2011
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAPWei Zhu, Huaguo Xu, DanXia Zhu, et al.
Molecular Cancer|October 15, 2025
Purine metabolism: a pan-cancer metabolic dysregulation across circulation and tissuesMengjie Yu, Cheng Liu, Minmin Cao, et al.
Clinical Science (London, England : 1979)|May 22, 2019
Hsa_circ_0009361 acts as the sponge of miR-582 to suppress colorectal cancer progression by regulating APC2 expressionYiting Geng, Xiao Zheng, Wenwei Hu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 20, 2018
IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUADChen Wu, Xiaodong Li, Dachuan Zhang, et al.
Pageof 5